Clinical Trials Directory

Trials / Sponsors / Neurim Pharmaceuticals Ltd.

Neurim Pharmaceuticals Ltd.

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingPiromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Alzheimer's Disease
Phase 2 / Phase 32022-05-12
WithdrawnEfficacy and Safety of Slenyto for Insomnia in Children With ASD
Autism Spectrum Disorder
Phase 32020-09-01
CompletedSafety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
Alzheimer's Disease
Phase 22015-11-01
CompletedEfficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disa
Sleep Disorders
Phase 32013-10-01
CompletedAssessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Distur
Sleep Problems
Phase 12013-03-01
CompletedSleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients
Primary Insomnia
Phase 22011-12-01
CompletedInvestigation of Melatonin and Zolpidem Effect on Postural Instability in Healthy Adult Subjects
Postural Instability
Phase 42011-01-01
CompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia
Insomnia
Phase 12010-04-01
CompletedEfficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
Alzheimer's Disease, Sleep Disorder
Phase 22009-09-01
TerminatedSafety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
Levodopa-induced Dyskinesia
Phase 1 / Phase 22008-03-01
CompletedEfficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
Primary Insomnia
Phase 32006-10-01
CompletedEfficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
Non-24 Hour Sleep-Wake Disorder, Blindness
Phase 22006-02-01
CompletedSleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
Primary Insomnia
Phase 21996-09-01
CompletedA Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Inso
Diabetes Mellitus, Type 2, Insomnia
Phase 21995-11-01